MedPath

Investigating the effect of Ginko biloba on attention deficit hyperactivity disorder symptoms

Phase 3
Conditions
Attention deficit hyperactivity disorder.
Attention-deficit hyperactivity disorders
Registration Number
IRCT20151123025202N31
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Age 5 to 15 years
Normal IQ

Exclusion Criteria

patients with neurological or organic disorder
Patients on a special diet

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome of the study includes changes in symptoms of ADHD including sleep quality, nutrition quality, growth rate, academic performance, cognitive status. Timepoint: Before treatment and one month after treatment. Method of measurement: Variables with the 26-question questionnaire of Connors, which contains questions about sleep quality, nutrition quality, growth rate, academic performance, and cognitive status.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath